Leukapheresis in rheumatoid arthritis association of clinical improvement with reversal of anergy
โ Scribed by Dr Sharon M. Wahl; Ronald L. Wilder; Ildy M. Katona; Larry M. Wahl; Janice B. Allen; Irwin Scher; John L. Decker
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 833 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.
## Abstract ## Objective To create greater understanding of the changes in synovial tissue parameters that occur in conjunction with clinical response by using an effective therapy, in order to facilitate the planning of future studies with therapeutic agents for rheumatoid arthritis (RA). ## Met